XML 62 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
Net Income (Loss) Per Share
3 Months Ended
Mar. 31, 2015
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share
11. NET INCOME (LOSS) PER SHARE

Basic net income (loss) per share is computed using the weighted average number of common shares outstanding for the period, excluding unvested restricted stock and RSUs. Diluted net income per share is based upon the weighted average common shares outstanding for the period plus dilutive potential shares including unvested restricted stock, RSUs, and stock options using the treasury stock method. The following is a reconciliation of the numerators and denominators used in computing basic and diluted net income (loss) per share:

 

     Three Months Ended
March 31,
 
     2015     2014  
     (in thousands except
per share amounts)
 

Numerator:

    

Net income (loss)

   $ (59   $ 1,864   
  

 

 

   

 

 

 

Denominator:

Shares used in computation of basic net income (loss) per share (weighted average common shares outstanding)

  27,818      28,370   

Dilutive potential common shares:

Restricted Stock and RSUs

  0      316   

Stock options

  0      696   
  

 

 

   

 

 

 

Shares used in computation of diluted net income (loss) per share

  27,818      29,382   
  

 

 

   

 

 

 

Basic net income (loss) per share

$ 0.00    $ 0.07   
  

 

 

   

 

 

 

Diluted net income (loss) per share

$ 0.00    $ 0.06   
  

 

 

   

 

 

 

As of March 31, 2015, the Company had securities outstanding that could potentially dilute basic earnings per share in the future, but these were excluded from the computation of diluted net loss per share for the three months ended March 31, 2015, since their effect would have been anti-dilutive. These outstanding securities consisted of the following:

 

     March 31,  
     2015  

Outstanding stock options

     3,875,153   

Unvested RSUs

     565,148   

For the three months ended March 31, 2014, options to purchase approximately 1.4 million shares of common stock with exercise prices greater than the average fair market value of the Company’s stock of $11.21 per share were not included in the calculation because the effect would have been anti-dilutive.